Bio View Ltd. (BIOV)
TASE
81.30
-2.20 (-2.63%)
Closed
Aug 25, 2026
Day's Range
80.4084.50
52 wk Range
80.40294.00
Financial Statements - BIOV - Bio View Ltd.
Revenue
19.93M▼ 22.3%
Net Income
-15.33M▼ 387.0%Net Margin -76.9%
EBITDA
-7.07M▼ 650.2%
Free Cash Flow
-3.11M▲ 1.0%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 19.93M | 25.65M | 34.76M | 29.14M | 30.51M | 25.96M |
| Cost of Goods | 10.41M | 10.09M | 13.39M | 12.47M | 12.92M | 10.17M |
| Gross Profit | 9.51M | 15.56M | 21.37M | 16.67M | 17.58M | 15.78M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -7.80M | -2.97M | 630K | 103K | 3.55M | 2.17M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | -9.14M | -2.85M | 797K | 875K | 2.68M | 1.14M |
| Income Tax | 6.18M | 291K | 414K | 288K | 499K | 257K |
| Net Income | -15.33M | -3.14M | 383K | 587K | 2.18M | 884K |
| EPS Basic | -0.113 | -0.24 | 0.03 | 0.005 | 0.016 | 0.006 |
| EPS Diluted | -0.113 | -0.24 | 0.03 | 0.005 | 0.016 | 0.006 |
| Basic Shares Outstanding | 135.63M | 13.28M | 13.54M | 135.40M | 139.76M | 140.60M |
| Diluted Shares Outstanding | 135.63M | 13.28M | 13.54M | 135.40M | 139.76M | 140.60M |
| Ebit | -9.02M | -2.64M | 1.10M | 1.11M | 2.91M | 1.18M |
| Ebitda | -7.07M | -943K | 2.92M | 2.60M | 4.40M | 2.41M |
| Net Income Continuous Operations | -9.14M | -2.85M | 797K | 875K | 2.68M | 1.14M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
